The inhibition of USP7, able to affect the stability of the AR isoforms but also that of proteins like CCDC6 involved in HR impairment, might be able to sensitize hormone-sensitive and hormone-resistant prostate carcinoma to PARP inhibition [41]. Here, PARP1 is linked to prostate carcinoma.